Bowman Lacrimal Probe

Bowman Lacrimal Probe Market Outlook

The global Bowman Lacrimal Probe market is anticipated to reach a valuation of approximately USD 125 million by 2035, growing at a CAGR of around 5% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing prevalence of lacrimal duct disorders, advancements in minimally invasive surgical techniques, and rising awareness regarding ocular health. Moreover, the aging population and the subsequent rise in eye-related conditions are expected to further drive the demand for Bowman Lacrimal Probes. The expanding healthcare infrastructure, especially in emerging economies, will also contribute significantly to the market expansion over the coming years.

Growth Factor of the Market

The Bowman Lacrimal Probe market is poised for significant growth due to several factors that are enhancing its demand across healthcare settings. One key driver is the rising incidence of lacrimal duct obstructions, which necessitate efficient diagnostic and surgical tools such as Bowman Lacrimal Probes for effective treatment. Furthermore, improvements in healthcare facilities and technologies are enabling more precise and less invasive procedures that favor the use of Bowman Probes. Moreover, the increasing emphasis on early diagnosis and treatment of ocular conditions is fostering greater utilization of these probes in clinical practice. As the population ages, the susceptibility to eye disorders is likely to increase, thereby promoting the demand for Bowman Lacrimal Probes. Additionally, the growth of specialized clinics focusing on eye care plays a crucial role in bolstering the market further.

Key Highlights of the Market

• The global Bowman Lacrimal Probe market is expected to grow at a CAGR of 5% from 2025 to 2035.
• North America holds the largest market share, driven by advanced healthcare facilities and rising awareness.
• Stainless steel remains the most preferred material type due to its durability and ease of sterilization.
• The demand for specialty clinics is increasing, enhancing the availability of lacrimal probe technologies.
• Technological advancements in the design of Bowman Lacrimal Probes are improving procedural outcomes.

By Product Type

Straight Bowman Lacrimal Probe:

Straight Bowman Lacrimal Probes are predominantly used in diagnostic procedures and are characterized by their simple and effective design. These probes are straight with a tapered end, which allows for easy insertion into the lacrimal duct. Their straightforward design makes them user-friendly and suitable for both novice practitioners and experienced surgeons. The growing prevalence of eye disorders related to lacrimal drainage systems has increased the use of these probes in clinical settings. The adoption of straight Bowman Lacrimal Probes is expected to witness steady growth due to their reliability and efficacy in providing accurate diagnoses and facilitating treatment procedures.

Angled Bowman Lacrimal Probe:

Angled Bowman Lacrimal Probes are designed ergonomically to access challenging anatomical areas of the lacrimal system. The angled tip allows for better navigation within the duct, making these probes particularly valuable during treatments of complex lacrimal duct obstructions. Their specific design enhances visibility and control during procedures, which leads to improved surgical outcomes. As minimally invasive techniques become the preferred choice among healthcare professionals, the demand for angled Bowman Lacrimal Probes is predicted to increase significantly, thereby driving market growth in this segment.

Curved Bowman Lacrimal Probe:

Curved Bowman Lacrimal Probes are specialized tools designed to navigate the anatomical curvature of the lacrimal drainage system effectively. These probes are particularly useful in surgical interventions that require precision and accuracy. With their unique design, curved probes can provide better access and visibility compared to straight probes in certain cases. As the awareness regarding the importance of specialized tools in surgical procedures grows, the adoption of curved Bowman Lacrimal Probes is likely to rise, further contributing to the market's growth.

Flexible Bowman Lacrimal Probe:

Flexible Bowman Lacrimal Probes represent a vital innovation in the field of ophthalmic surgery, allowing for maneuverability and adaptability in various anatomical conditions. The flexibility of these probes facilitates the navigation of the sac and duct without causing trauma to the surrounding tissues. They are especially beneficial in pediatric cases where anatomical structures can vary significantly. The market for flexible Bowman Lacrimal Probes is expected to expand as surgical techniques continue to evolve, and healthcare practitioners increasingly adopt instruments that enhance patient safety and procedural efficiency.

Hollow Bowman Lacrimal Probe:

Hollow Bowman Lacrimal Probes provide an added advantage of irrigation and aspiration during procedures, which can be particularly useful in managing lacrimal duct obstructions. These probes allow for simultaneous fluid delivery and removal, enhancing the effectiveness of treatments. The versatility of hollow probes makes them a preferred choice among surgeons handling various lacrimal drainage issues. As advancements in combined treatment techniques gain popularity, the demand for hollow Bowman Lacrimal Probes is anticipated to grow, contributing to the overall market expansion.

By Application

Dacryocystitis Diagnosis:

The diagnosis of dacryocystitis, an inflammation of the lacrimal sac, often necessitates the use of Bowman Lacrimal Probes for thorough examination and assessment. These probes enable healthcare providers to evaluate the condition of the lacrimal duct and identify any blockages or abnormalities. As the incidence of dacryocystitis rises, particularly among older adults and individuals with underlying medical conditions, the reliance on Bowman Lacrimal Probes for accurate diagnosis becomes increasingly crucial. The demand for these probes in diagnostic applications is set to witness substantial growth as awareness surrounding ocular health continues to rise.

Lacrimal Duct Obstruction Treatment:

Treating lacrimal duct obstructions is one of the primary applications of Bowman Lacrimal Probes, which are essential for various surgical interventions aimed at restoring normal drainage. These probes play a vital role in procedures such as probing and irrigating the lacrimal system, allowing for the removal of obstructions. The growing prevalence of conditions leading to lacrimal duct obstructions, such as age-related degeneration, contributes significantly to the demand for Bowman Lacrimal Probes in treatment applications. As healthcare professionals increasingly emphasize effective and timely interventions, the market for these probative instruments is projected to expand correspondingly.

Tear Duct Surgery:

Tear duct surgery is an increasingly common procedure that addresses various lacrimal system issues, and Bowman Lacrimal Probes are integral to achieving success in these operations. These probes assist surgeons in navigating the delicate structures of the tear drainage system, ensuring minimal trauma and maximal efficacy. The rise in tear duct surgeries is driven by the growing awareness of eye health and the importance of addressing lacrimal issues to improve quality of life. As surgical techniques continue to evolve and improve, the significance of Bowman Lacrimal Probes in tear duct surgeries is expected to rise, enhancing their market presence.

Others:

In addition to the primary applications mentioned, Bowman Lacrimal Probes also find utility in various other ophthalmic procedures. These may include diagnostic assessments for different lacrimal pathologies and adjunctive therapies for managing eye health. The versatility of Bowman Lacrimal Probes allows them to be adapted for use in various surgical contexts outside of the typical applications. As healthcare practitioners explore innovative approaches to ocular treatment, the segment for 'Other' applications is expected to grow, reflecting the broadening scope of Bowman lacrimal probes.

By Distribution Channel

Hospitals:

Hospitals serve as one of the primary distribution channels for Bowman Lacrimal Probes, given the extensive range of surgical and diagnostic procedures conducted within these facilities. The presence of specialized departments, such as ophthalmology, enhances the demand for these instruments, as they are integral to the treatment of various eye conditions. Moreover, hospitals frequently procure high-quality medical instruments to ensure optimal patient care and safety, further driving the demand for Bowman Lacrimal Probes. As hospitals continue to advance their surgical capabilities and technologies, this channel will likely maintain a significant share of the market.

Specialty Clinics:

Specialty clinics focusing on eye care and ophthalmology are increasingly becoming vital distribution channels for Bowman Lacrimal Probes. These clinics often provide more personalized care and specialized services, which fosters a demand for precise and effective diagnostic tools. The rise of specialty clinics is a response to the growing need for targeted healthcare solutions, leading to increased investment in advanced instruments. As awareness around eye health continues to grow, and patients seek specialized care, the market for Bowman Lacrimal Probes within specialty clinics is expected to flourish.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are emerging as significant distribution points for Bowman Lacrimal Probes, particularly due to their focus on outpatient procedures. These centers offer a cost-effective alternative for patients undergoing surgeries, which is driving the demand for effective and reliable surgical instruments. With the shift towards outpatient care and minimally invasive procedures, ASCs are increasingly adopting Bowman Lacrimal Probes for their surgical requirements. This trend is likely to grow as patient preferences move towards convenient and efficient healthcare solutions, augmenting the market presence of Bowman Lacrimal Probes within this channel.

Online Retail:

Online retail has transformed the way medical instruments are procured, including Bowman Lacrimal Probes. The convenience of online purchasing, coupled with the ability to compare prices and products, has led to a growing trend of sourcing medical supplies through e-commerce platforms. This distribution channel provides healthcare practitioners with flexible options for acquiring high-quality probes while ensuring broader accessibility. As online retail continues to expand and evolve, driven by technological advancements and changing consumer behaviors, the market for Bowman Lacrimal Probes through this channel is expected to rise significantly.

By Material Type

Stainless Steel:

Stainless steel is the most preferred material for Bowman Lacrimal Probes due to its strength, durability, and resistance to corrosion. The ability to withstand repeated sterilization cycles without losing integrity makes stainless steel an ideal choice for medical instruments. Furthermore, its smooth surface helps reduce friction during procedures, thereby ensuring better patient comfort. As healthcare institutions prioritize quality and safety, the reliance on stainless steel Bowman Lacrimal Probes will likely maintain its dominance in the market, reinforcing its position as the material of choice for manufacturers and practitioners alike.

Titanium:

Titanium Bowman Lacrimal Probes are gaining traction due to their lightweight nature and biocompatibility, making them suitable for surgical use in sensitive ocular procedures. The unique properties of titanium, such as resistance to corrosion and non-reactiveness with bodily tissues, enhance patient safety and comfort during interventions. Though they may be more expensive than stainless steel alternatives, the long-term benefits of titanium probes, including durability and reduced risk of infection, are driving their adoption in the market. As healthcare evolves towards safer and more effective materials, the use of titanium Bowman Lacrimal Probes is expected to increase steadily.

Plastic:

Plastic Bowman Lacrimal Probes offer a cost-effective alternative to their metal counterparts and are particularly useful in single-use applications. Their lightweight and flexible nature allow for ease of handling during procedures, making them a popular choice in outpatient settings. While they may not offer the same level of durability as metal probes, their disposable nature minimizes the risk of cross-contamination and infection. The demand for plastic Bowman Lacrimal Probes is likely to grow, particularly in environments where single-use instruments are preferred for reasons of hygiene and safety.

Silicon:

Silicon Bowman Lacrimal Probes provide a unique combination of flexibility and softness, making them ideal for use in delicate ocular procedures. The non-reactive nature of silicon reduces the risk of irritation or allergic reactions during surgical interventions, which is particularly beneficial for sensitive patients. As the healthcare sector continues to focus on patient-centered care, the demand for silicon lacrimal probes is expected to grow. The ability of silicon probes to conform to various anatomical structures enhances their suitability in a range of applications, thereby contributing positively to the market.

Others:

The category of 'Others' includes various alternative materials used for Bowman Lacrimal Probes that may not fit the standard classifications. These can include composite materials or innovative biodegradable options that are emerging in the market. As the medical industry evolves, there is a growing emphasis on sustainability and environmentally friendly materials, which may prompt manufacturers to explore new options. The demand for alternative materials in the Bowman Lacrimal Probe segment is likely to increase as practitioners and healthcare facilities seek to adopt more sustainable practices in medical instrument procurement.

By Region

The North American region holds a prominent position in the Bowman Lacrimal Probe market, accounting for over 35% of the global market share in 2025. This dominance can be attributed to advanced healthcare systems, robust research and development activities, and high levels of investment in ophthalmic technology. The increasing prevalence of lacrimal duct-related disorders, coupled with a strong focus on eye healthcare, is expected to further bolster market growth in this region. Furthermore, the presence of leading companies and significant healthcare infrastructure supports the growth trajectory, with a projected CAGR of 5.5% through 2035.

Europe also represents a significant portion of the Bowman Lacrimal Probe market, comprising approximately 30% of the global market share. The region benefits from a well-established healthcare system and a high level of awareness regarding ocular health. Countries such as Germany, France, and the United Kingdom are leading contributors to market growth, driven by a rising incidence of eye-related disorders and a growing population of elderly individuals. As healthcare practices evolve and new surgical techniques are adopted, the European market for Bowman Lacrimal Probes is expected to experience steady growth, with a projected CAGR of 4.5% over the forecast period.

Opportunities

The Bowman Lacrimal Probe market presents several opportunities for growth, particularly with the increasing emphasis on advanced ophthalmic technologies and minimally invasive procedures. As patients become more informed about their healthcare options, there is a growing demand for innovative surgical instruments that enhance procedural outcomes and minimize recovery times. Manufacturers can capitalize on this opportunity by investing in research and development to create technologically advanced Bowman Lacrimal Probes with improved ergonomics and functionality. Furthermore, partnerships with healthcare institutions and specialized clinics can enable manufacturers to expand their reach and influence in the market, fostering collaborative innovations that meet evolving patient needs.

Another significant opportunity lies in the expansion of telemedicine and remote healthcare services, which are reshaping the landscape of patient care. As healthcare providers increasingly adopt telehealth solutions, there is potential for the integration of Bowman Lacrimal Probes into remote diagnostic and treatment protocols. This trend could enhance accessibility for patients in rural or underserved areas, driving demand for these instruments in new markets. Additionally, the emerging trend of personalized medicine offers an opportunity for the development of customized Bowman Lacrimal Probes tailored to specific patient needs, further driving market growth and diversification.

Threats

While the Bowman Lacrimal Probe market is poised for growth, it also faces several threats that could hinder its expansion. One major concern is the potential for regulatory changes that may impose stricter guidelines on the manufacturing and distribution of medical instruments. Such regulations could result in increased compliance costs and delays in bringing new products to market. Additionally, the presence of counterfeit medical instruments poses a significant risk, as these substandard products can compromise patient safety and efficacy. As healthcare institutions become more vigilant about the quality of instruments they use, the market may face challenges in maintaining trust and credibility.

Furthermore, competition from alternative diagnostic and treatment modalities could impede the market's growth trajectory. As newer technologies, such as advanced imaging systems and laser-based procedures, become more prevalent, the reliance on traditional Bowman Lacrimal Probes may decline. Additionally, the ongoing COVID-19 pandemic has created significant disruptions in healthcare services, leading to delayed elective surgeries, which could adversely affect the demand for Bowman Lacrimal Probes in the short term. Such external factors may continue to pose challenges, requiring stakeholders to adapt and innovate constantly.

Competitor Outlook

• Inami & Co., Ltd.
• Medtronic PLC
• Alcon Inc.
• Bausch Health Companies Inc.
• CooperVision, Inc.
• Hoya Corporation
• Katalyst Surgical, Inc.
• Accutome, Inc.
• Oculus Optikgeräte GmbH
• EyeGate Pharmaceuticals, Inc.
• Jiangsu Fuda Health Technology Co., Ltd.
• Shenzhen Bonad Instrument Co., Ltd.
• Hankang Medical Instruments Co., Ltd.
• Medline Industries, Inc.
• Vistakon, Inc.

The competitive landscape of the Bowman Lacrimal Probe market is characterized by the presence of established players and new entrants vying for market share. Key companies are focusing on product innovation, strategic partnerships, and geographic expansion to enhance their competitive positioning. The intense competition drives manufacturers to improve the quality and functionality of their probes, addressing a wider range of surgical requirements and adapting to evolving healthcare practices. As the market grows, players are likely to invest substantially in research and development to ensure that their offerings remain at the forefront of technology, catering to the needs of practitioners and patients alike.

Prominent players like Medtronic PLC and Alcon Inc. have established themselves as leaders in the ophthalmic instruments market, including Bowman Lacrimal Probes, through their extensive product portfolios and strong distribution networks. Medtronic, known for its commitment to innovation, frequently invests in new technologies and surgical solutions that enhance procedural efficacy. Alcon, on the other hand, has a comprehensive range of ocular instruments and a significant global presence, allowing it to leverage market opportunities effectively and maintain its competitive edge.

Bausch Health Companies Inc. and CooperVision, Inc. are also notable competitors in the market, focusing on expanding their product lines to include advanced medical devices catering to various ocular conditions. Bausch Health emphasizes its commitment to eye health through its wide array of surgical instruments, while CooperVision is recognized for its innovative approach in contact lens technology, which complements its surgical products. Companies like Jiangsu Fuda Health Technology Co., Ltd. and Shenzhen Bonad Instrument Co., Ltd. are emerging as strong regional players, offering competitively priced products that appeal to local markets.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Alcon Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic PLC
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Accutome, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Vistakon, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Hoya Corporation
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Inami & Co., Ltd.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 CooperVision, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Katalyst Surgical, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Medline Industries, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Bausch Health Companies Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 EyeGate Pharmaceuticals, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Oculus Optikgeräte GmbH
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Shenzhen Bonad Instrument Co., Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Hankang Medical Instruments Co., Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Jiangsu Fuda Health Technology Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Bowman Lacrimal Probe Market, By Application
    • 6.1.1 Dacryocystitis Diagnosis
    • 6.1.2 Lacrimal Duct Obstruction Treatment
    • 6.1.3 Tear Duct Surgery
    • 6.1.4 Others
  • 6.2 Bowman Lacrimal Probe Market, By Product Type
    • 6.2.1 Straight Bowman Lacrimal Probe
    • 6.2.2 Angled Bowman Lacrimal Probe
    • 6.2.3 Curved Bowman Lacrimal Probe
    • 6.2.4 Flexible Bowman Lacrimal Probe
    • 6.2.5 Hollow Bowman Lacrimal Probe
  • 6.3 Bowman Lacrimal Probe Market, By Material Type
    • 6.3.1 Stainless Steel
    • 6.3.2 Titanium
    • 6.3.3 Plastic
    • 6.3.4 Silicon
    • 6.3.5 Others
  • 6.4 Bowman Lacrimal Probe Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Online Retail

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Bowman Lacrimal Probe Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Bowman Lacrimal Probe market is categorized based on

By Product Type

• Straight Bowman Lacrimal Probe
• Angled Bowman Lacrimal Probe
• Curved Bowman Lacrimal Probe
• Flexible Bowman Lacrimal Probe
• Hollow Bowman Lacrimal Probe

By Application

• Dacryocystitis Diagnosis
• Lacrimal Duct Obstruction Treatment
• Tear Duct Surgery
• Others

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Online Retail

By Material Type

• Stainless Steel
• Titanium
• Plastic
• Silicon
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Inami & Co., Ltd.
• Medtronic PLC
• Alcon Inc.
• Bausch Health Companies Inc.
• CooperVision, Inc.
• Hoya Corporation
• Katalyst Surgical, Inc.
• Accutome, Inc.
• Oculus Optikgeräte GmbH
• EyeGate Pharmaceuticals, Inc.
• Jiangsu Fuda Health Technology Co., Ltd.
• Shenzhen Bonad Instrument Co., Ltd.
• Hankang Medical Instruments Co., Ltd.
• Medline Industries, Inc.
• Vistakon, Inc.